Results 61 to 70 of about 164,322 (206)
Practical Recommendations for Anticoagulation in Patients With Atrial Fibrillation
European Journal of Clinical Investigation, Volume 56, Issue 5, May 2026.Oral anticoagulation (OAC) reduces stroke risk by at least two thirds and mortality by one fourth. The threshold for net clinical benefit of OAC is met when stroke risk exceeds 1%–2% per year. Direct oral anticoagulants (DOACs) are preferred to vitamin K antagonists (VKAs) in most patients, including in the elderly and chronic kidney disease ...
Nicolas Johner, Baris Gencer
wiley +1 more source
Hypertrophic pyloric stenosis: tips and tricks for ultrasound diagnosis [PDF]
, 2012 We describe a systematic approach to the ultrasound (US) examination of the antropyloric region in children. US is the modality of choice for the diagnosis of hypertrophic pyloric stenosis (HPS).
Carlos Pina Vaz +13 more
core +4 more sources
Stricturing Diseases of the Gastrointestinal Tract—Current Clinical Practice
JGH Open, Volume 10, Issue 4, April 2026.ABSTRACT Gastrointestinal stricture can occur in the esophagus, stomach, small intestine, colon, and anorectum. Most of the strictures are benign. The prevalence of esophageal strictures (ES) secondary to eosinophilic esophagitis has increased. Pyloric stenosis (PS) is rarely seen in clinical practice.
Monjur Ahmed
wiley +1 more source
Tetrahydrobiopterin in the treatment of infantile hypertrophic pyloric stenosis.
, 1997 Evidence is emerging that reduced nitric oxide production may be involved in the pathogenesis of hypertrophic pyloric stenosis. Nitric oxide synthase (NOS) requires tetrahydrobiopterin (BH4) for activity.
Werner ER +5 more
core +1 more source
Minimally invasive approach to non-communicating pyloric duplication
Journal of Pediatric Surgery Case Reports, 2018 Pyloric duplication is a rare subset of alimentary tract duplications that can present in a manner almost identical to hypertrophic pyloric stenosis.
Patrick T. Delaplain +2 more
doaj +1 more source
Hypertrophic pyloric stenosis: Early presentation with hyperbilirubinemia [PDF]
, 2017 Hypertrophic Pyloric Stenosis commonly presents with non-bilious progressive vomiting usually after a feed. The vomiting usually starts after third week with a range of symptoms onset from first week to fifth month of life.
Maji, Prabir, Mishra, Rajeeva
core
Nitric oxide synthase activity in infantile hypertrophic pyloric stenosis.
, 1992 BACKGROUND: Hypertrophic pyloric stenosis is a common infantile disorder characterized by enlarged pyloric musculature and gastric-outlet obstruction. Its physiopathologic mechanism is not known, but a defect in pyloric relaxation (pylorospasm) has been ...
Schiffmann, Serge N. +9 more
core +1 more source
Citrullinemia type I and hypertrophic pyloric stenosis in a 1-month old male infant
Clinics and Practice, 2013 Citrullinemia type I (CTLN1) is an inherited urea cycle disorder, now included in most newborn screening panels in the US and Europe. Due to argininosuccinate synthetase deficiency, CTLN1 can lead to recurrent hyperammonemic crisis that may result in ...
Yoona Rhee +3 more
doaj +1 more source
Reviews in Medical Virology, Volume 36, Issue 2, March 2026.ABSTRACT This case report and systematic review describe the complete clinical course of chronic gastric ulceration complicating acute gastrointestinal CMV disease in a 72‐year‐old immunocompetent woman, with demonstrable response to ganciclovir but not valganciclovir.
Zayn Al‐Timimi +2 more
wiley +1 more source
American Journal of Medical Genetics Part A, Volume 200, Issue 2, Page 407-418, February 2026.ABSTRACT Costello syndrome (CS) is a rare dominant HRAS RASopathy characterized by curly hair, cardiac abnormalities, craniofacial anomalies, and developmental delay. HRAS codon 58, 59, and 60 variants are associated with milder phenotypes. We describe a three‐generation family with a previously unreported heterozygous HRAS variant c.175G>A (p.Ala59Thr)
Nikole Rautiainen +10 more
wiley +1 more source